MAIA Biotechnology, Inc.MAIANYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-20.15%
↑ 67% vs avg
Percentile
P40
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-60.50%
Historical baseline
PeriodValue
2024-20.15%
2023-8.06%
2022-193.39%
2021-123.56%
2020-17.83%
20190.00%